Livepandemic preparednessWestern cycleAnchors pending

By 2035, Africa will produce 60% of its own vaccines (up from 1% in 2021)?

As of 2 Oct · 12:00 UTCResolves 31 Dec 20353 movers2 pressure moments
Timeline A · Africa ScalesReality
35%
Crowd 55%Gap 0

By 2035, African countries operate vaccine factories that supply most of their own shots. Rwanda's mRNA plant and similar facilities across the continent produce routine vaccines, boosters, and new vaccines during outbreaks. African scientists lead vaccine research on the continent. Supply chains run through African ports and roads instead of waiting for imports.

Timeline B · Africa ShortReality
65%
Crowd 45%Gap 0

In 2035, Africa still imports most vaccines from Europe, the US, and Asia. Local factories exist but produce only a small share of what the continent uses. When new viruses emerge or supplies tighten, African countries wait for foreign manufacturers to fill orders. Vaccine security remains tied to decisions made outside Africa.

crowd 55
The quiet paththe one nobody’s watching

Oral or room-temperature vaccine tech could make the manufacturing race irrelevant.

6%
The read
Reality still leans toward Africa Short.

Reality points at Africa Short — the dominant pressures today support that outcome over Africa Scales. The main thing that could shift this is mRNA facility performance (BioNTech Rwanda, Institut Pasteur Dakar).

Where reality is heading

A, 80% bandCrowd today
Projected reality support to 31 Dec 2028A rises from 41% to about 52% with an 80% band of 33 to 71. B falls from 53% to about 44%. Quiet path near 4 to 6%. Crowd today: A 55%.100%7550250Crowd today · A 55%A ~52%B ~44%P ~4%NowJan 2027Jan 202831 Dec 2028
Reality crosses toward A in early 2028. Today’s crowd number sits at the top of A’s band, possible but optimistic. View as table

The movers, ranked by leverage

01
Global health institutionActor-class for institutions whose role is pathogen surveillance, pandemic preparedness, vaccine R&D coordination, and global health governance. WHO, CEPI, Pandemic Fund, Africa CDC, Quadripartite AMR body, GAVI, national CDCs operating at international mandate. Direction typically Timeline-A on health-system-stability cycle via codification work; Timeline-B when the institution degrades or is rejected (decodification per Form 6).
leverage 55
Global health bodies codify or decay depending on legitimacy inflows.
02
Collective pull shiftMarket-class: discontinuous move in collective attention + capital toward an outcome, measurable in prediction markets (Polymarket / Kalshi / Manifold / Metaculus / PredictIt) and sector-rotation flows. Per AMENDMENT 47 §MCA-2, this IS the B_leak = consciousness measurement instrument where it covers an outcome. Direction contextual depending on which outcome the pull targets.
leverage 50
Prediction markets reprice when collective pull on an outcome moves.
03
Institutional trust decaySignal-class: measurable datum tracking collective trust in institutions — Pew/Gallup polling on Congress/Supreme-Court/media/science/business, approval ratings, cross-party cooperation rate, voter-turnout participation vs grievance, protest-event counts. Direction typically Timeline-B on democratic-haywire cycle.
leverage 55
Falling institutional trust accelerates the destabilization timeline.

What would change our mind

Signals toward A
  • mRNA facility performance (BioNTech Rwanda, Institut Pasteur Dakar) moving in support of Africa Scales
  • Procurement commitments from African Union shifting in the direction that supports Africa Scales
  • Technology-transfer breakthroughs crossing the threshold toward Africa Scales
  • Fresh readings from AU Assembly (2022-02-01) — Africa CDC elevation to continental agency pointing toward Africa Scales
Signals toward B
  • mRNA facility performance (BioNTech Rwanda, Institut Pasteur Dakar) moving in support of Africa Short
  • Procurement commitments from African Union shifting in the direction that supports Africa Short
  • Technology-transfer breakthroughs holding against the shift toward Africa Short
  • Fresh readings from BioNTech Rwanda facility (2023-12-01) — mRNA facility operational pointing toward Africa Short

Pressure moments

A zoonotic spillover amplifies to pandemic riskH5N1 clade 2.3.4.4b dairy-cattle outbreak scope + bovine-to-human transmission events · WHO IHR notifications of novel-pathogen clusters · Nextstrain phylogenetic reconstruction of mammalian-adaptation mutations
Multi-year surveillance window; discrete amplification event; multi-year downstream regime
High
Global health governance architecture codifiesWHO Pandemic Agreement adoption + ratification counts · IHR 2024 amendment opt-out/reservation count · CEPI 100-day mission real-pathogen validation
3-7 year codification phase; cumulative over multi-decade institutional buildout
High

Evidence